Keith Wayne Ward

Insider Reports History

Location
Raleigh, NC
Signature
/s/ Kaitlyn Arsenault, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Keith Wayne Ward:

Company Role Class Num Shares Value Price $ Report Date Ownership
Skye Bioscience, Inc. Director Stock Option (Right to Buy) 35,000 $595 $0.0170 29 Feb 2024 Direct

Insider Reports Filed by Keith Wayne Ward

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SKYE Skye Bioscience, Inc. 29 Feb 2024 1 $0 4 Director 04 Mar 2024, 06:23
SKYE Skye Bioscience, Inc. 06 Nov 2023 1 $0 4 Director 06 Nov 2023, 20:32
SKYE Skye Bioscience, Inc. 25 Aug 2023 1 $0 4 Director 29 Aug 2023, 19:17
SKYE Skye Bioscience, Inc. 05 Jan 2023 1 $0 4 Director 09 Jan 2023, 09:42
SKYE Skye Bioscience, Inc. 14 Dec 2021 1 $0 4 Director 16 Dec 2021, 17:50
SKYE Skye Bioscience, Inc. 14 Dec 2021 0 $0 3 Director 16 Dec 2021, 17:43